Assisted Reproductive Technologies Market Size, Share and Global Trend By Type (In Vitro Fertilization, Intracytoplasmic Sperm Injection, Gamete Intrafallopian Transfer, Tubal Embryo Transfers), By End User (Hospitals, Fertility Centers) and Geography Forecast till 2030

Majority of couples are facing the problem of infertility due to factors such as mental stress, health problems, and sedentary lifestyle. Certain conditions such as failure to ovulation, problems in menstrual cycles, infections, polycystic ovary syndrome, etc. are responsible for causing infertility in females. On the other hand, difficulties in sperm formation and sperm transport are responsible for causing impotence in males.

According to Eunice Kennedy Shriver National Institutes of Child Health and Human Development, an estimated 10.0%-20.0% of infertility in males is caused due to the transport of sperm from testicles to penis. Traditional infertility treatment includes techniques such as artificial insemination, surrogacy, ovulation induction, and others.

To gain extensive insights into the market, Download for Customization

Assisted reproductive technology includes manipulation of eggs and sperm/embryo outside the human body to treat infertility. There are certain types of assisted reproductive technologies such as in vitro fertilization, surrogacy, cryopreservation, and others. The increase in a number of infertility clinics and higher success rates have increased the demand for assisted reproductive technologies.

Rapid adoption to sedentary lifestyle leading to stress, rising prevalence of infertility, rapid adoption of unhealthy habits such as smoking, excessive consumption of alcohol, lack of physical exercise and hormonal imbalance amongst males and females are the factors driving the growth in the global assisted reproductive technologies market.

Moreover, rising prevalence of certain chronic conditions such as diabetes, obesity, chromosome defects, and uterine problems leading to infertility in both, males and females offers the higher opportunity for increased adoption of assisted reproductive technologies. Also, advantages of assisted reproductive technology such as higher success rates amongst all ages and minimal side effects are expected to boost the demand for assisted reproductive technologies during the forecast period.

However increased risk of multiple pregnancies, damage of fallopian tubes, higher treatment costs, and risk of the severe ovarian hyper-stimulation syndrome are factors that can hinder the growth in the global assisted reproductive technologies.

Key Players Covered

Some of the major companies that are present in the global assisted reproductive technologies market are CooperSurgical, Inc., Microm Ltd., Merck KGAa, Hamilton Thorne, Inc., Anecova, OvaScience, Inc., Parallabs Ltd., Bloom Fertility Centre, California Cryobank, Esco Micro Pte Ltd., Nidacon International AB, Vitrolife, and others.

SEGMENTATION

Among the segmentation, in vitro fertilization segment is projected to hold a considerable share of the global assisted reproductive technologies market during the forecast period. In July 2018, Merck & Co., Inc. announced the launch of QBOX IVF and Geri Assess 2.0, which is expected to augment the in vitro fertilization segment in the global assisted reproductive technologies market.

Key Insights

• Prevalence of infertility for key countries
• The regulatory scenario for key countries
• Reimbursement scenario for key countries
• New product launches
• Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

North America is anticipated to dominate the global assisted reproductive technologies market in the forecast duration owing to the rapid adoption of advanced technologies. According to National Institutes of Health, an estimated 9.0% of males and 11.0% of females are suffering from infertility in the U.S. each year, which is likely to favor the assisted reproductive technologies market in North America. In Asia Pacific, the assisted reproductive technologies market is expected to have the significant growth owing to the rising prevalence of infertility and increased government interventions on women health.

Key Industry Developments

• In July 2018, Merck & Co., Inc. announced the launch of QBOX IVF and Geri Assess 2.0, in order to meet customer needs and increase preference among IVF stakeholders.
• In August 2017, Hamilton Thorne Ltd. launched TrakJector micromanipulator system with the aim to offer unique solution in assisted reproductive technology laboratory for embryo biopsy procedures.
• In January 2016, Mercer LLC announced startegic collaboration with Progyny to provide innovative Science and Member-Driven Assisted Reproductive Technology (SMART) to employees and employers, enbling companies to reduce meternity-related cost.